Answers are grounded in this paper and cite their sources.
While 4 π radiotherapy has shown dosimetric advantages over coplanar delivery, prior studies have assumed a fixed source-to-isocenter distance (SID), as varying SID is cumbersome to implement on conventional C-arm linacs. Radiotherapy platforms based on articulated robotic arms eliminate this constraint, enabling non-coplanar, non-isocentric delivery with variable SIDs without moving the patient. Larger SIDs offer increased per-field tumor coverage with a larger field-of-view (FOV), while shorter SIDs improve modulation resolution. This study combines multiple SIDs to simultaneously achieve high target coverage and modulation resolution in robotic radiotherapy. A Multi-SID optimization framework was developed for simultaneous beam orientation optimization, isocenter selection, SID selection, and fluence map optimization. The planning cost includes a least-squares dose fidelity objective, a total variation term for fluence smoothness, and a group sparsity term for beam orientation, SID, and isocenter selection. The collision-free candidate beam pool includes over 1000 beam orientations, 10 SID levels (50–95 cm), and 5–9 isocenters. Multi-SID 4 π intensity-modulated radiation therapy (IMRT) plans were compared against fixed-SID (SID-50 cm and SID-100 cm) 4 π IMRT plans on 10 head-and-neck (H&N) cancer cases. Multi-SID consistently achieved superior plan quality across all 10 patients using varying beams (10–30). For 15-beam plans, the planning target volume homogeneity (defined as D95/D5) is (0.898, 0.893, 0.889), dose conformity (using the Paddick Conformity Index) is (0.867, 0.853, 0.837), the mean Organs-at-Risk (OAR) dose is (12.67, 15.05, 14.12), and the R50 is (2.429, 2.575, 2.485) for Multi-SID, SID-100, and SID-50 respectively. Wilcoxon signed-rank testing showed that the improvements in homogeneity, conformity, and OAR sparing with Multi-SID were statistically significant. Our Multi-SID method leverages both high target coverage and modulation resolution to achieve better dosimetry and/or more efficient treatment plans than fixed SID methods.
No takes yet. Share an insight, caveat, or question.
YU et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: